Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread

2005, Neuraminidase inhibitors for influenza., N Engl J Med, 353, 1363, 10.1056/NEJMra050740

WHO 2005 Responding to the avian influenza pandemic threat: Recommended strategic actions The World Health Organization Available: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_8/en/index.html. Accessed 2 November 2007.

2004, Resistant influenza A viruses in children treated with oseltamivir: Descriptive study., Lancet, 364, 59

2005, Oseltamivir resistance during treatment of influenza A (H5N1) infection., N Engl J Med, 353, 2667, 10.1056/NEJMoa054512

2003, A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals., J Antimicrob Chemother, 51, 977, 10.1093/jac/dkg136

2006, Emergence of drug-resistant influenza virus: Population dynamical considerations., Science, 312, 389, 10.1126/science.1122947

2007, Antiviral resistance and the control of pandemic influenza., PLoS Med, 4

2007, Detecting emerging transmissibility of avian influenza virus in human households., PLoS Computational Biology, 3

2000, Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial., JAMA, 283, 1016, 10.1001/jama.283.8.1016

2001, Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir., J Infect Dis, 183, 523, 10.1086/318537

2001, Oral oseltamivir treatment of influenza in children., Pediatr Infect Dis J, 20, 127, 10.1097/00006454-200102000-00002

2005, Avian flu: Isolation of drug-resistant H5N1 virus., Nature, 437, 1108, 10.1038/4371108a

2006, Recovery of drug-resistant influenza virus from immunocompromised patients: A case series., J Infect Dis, 193, 760, 10.1086/500465

2002, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets., Antiviral Res, 54, 99, 10.1016/S0166-3542(01)00214-5

2004, Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets., J Infect Dis, 190, 1627, 10.1086/424572

2005, Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility., Antimicrob Agents Chemother, 49, 4075, 10.1128/AAC.49.10.4075-4084.2005

1994, Within-host population dynamics and the evolution and maintenance of microparasite virulence., American Naturalist, 144, 457, 10.1086/285686

2002, Within-host population dynamics and the evolution of microparasites in a heterogeneous host population., Evolution Int J Org Evolution, 56, 213, 10.1111/j.0014-3820.2002.tb01332.x

2002, Modeling host-parasite coevolution: A nested approach based on mechanistic models., J Theor Biol, 218, 289, 10.1006/jtbi.2002.3076

2003, Within-host parasite dynamics, emerging trade-off, and evolution of virulence with immune system., Evolution Int J Org Evolution, 57, 1489, 10.1111/j.0014-3820.2003.tb00357.x

NowakMAMayRM 2000 Virus dynamics Oxford: Oxford University Press

2002, Modelling viral and immune system dynamics., Nat Rev Immunol, 2, 28, 10.1038/nri700

2006, Kinetics of influenza A virus infection in humans., J Virol, 80, 7590, 10.1128/JVI.01623-05

2006, Influenza and the challenge for immunology., Nat Immunol, 7, 449, 10.1038/ni1343

2004, Defense mechanisms against influenza virus infection in the respiratory tract mucosa., Jpn J Infect Dis, 57, 236, 10.7883/yoken.JJID.2004.236

2003, Models of CD8+ responses: 1. What is the antigen-independent proliferation program., J Theor Biol, 221, 585, 10.1006/jtbi.2003.3208

1996, Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza., JAMA, 275, 295, 10.1001/jama.1996.03530280047035

1986, Measurement of the mutation rates of animal viruses: Influenza a virus and poliovirus type 1., J Virol, 59, 377, 10.1128/JVI.59.2.377-383.1986

1993, Rates of spontaneous mutation among rna viruses., Proc Natl Acad Sci U S A, 90, 4171, 10.1073/pnas.90.9.4171

2006, Comparison of the mutation rates of human influenza A and B viruses., J Virol, 80, 3675, 10.1128/JVI.80.7.3675-3678.2006

2006, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro., J Antimicrob Chemother, 58, 723, 10.1093/jac/dkl321

2002, Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo., Antiviral Res, 54, 79, 10.1016/S0166-3542(01)00215-7

2002, The h274y mutation in the influenza a/h1n1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo., Antiviral Res, 55, 307, 10.1016/S0166-3542(02)00053-0

FennWRahnH 1964 Handbook of physiology, respiration volume 1 Bethesda (Maryland) American Physiological Society

1997, Upper respiratory tract surface areas and volumes of laboratory animals and humans: Considerations for dosimetry models., J Toxicol Environ Health, 50, 475, 10.1080/00984109708984003

FarmerSGHayDWP 1991 The airway epithelium New York Marcel Dekker

1999, Performance of virus isolation and directigen flu A to detect influenza A virus in experimental human infection., J Clin Virol, 14, 191, 10.1016/S1386-6532(99)00058-X

2006, Fatal outcome of human influenza a (h5n1) is associated with high viral load and hypercytokinemia., Nat Med, 12, 1203, 10.1038/nm1477

2004, Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice., J Gen Virol, 85, 2339, 10.1099/vir.0.79892-0

2006, A “partitioned leaping” approach for multiscale modeling of chemical reaction dynamics., J Chem Phys, 125, 144107, 10.1063/1.2354085

1999, Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza a virus., J Infect Dis, 180, 10, 10.1086/314823

1998, Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense., J Clin Invest, 101, 643, 10.1172/JCI1355

1999, Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment., J Infect Dis, 180, 586, 10.1086/314938

AndersonRMMayRM 1991 Infectious diseases of humans—Dynamics and control Oxford Oxford Science Publications

2006, Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic., Vaccine, 24, 6701, 10.1016/j.vaccine.2006.05.067

2007, How generation intervals shape the relationship between growth rates and reproductive numbers., Proc Roy Soc B, 274, 599, 10.1098/rspb.2006.3754

2004, Immune responses and the emergence of drug-resistant virus strains in vivo., Proc Roy Soc Lond B, 271, 1101, 10.1098/rspb.2003.2664

2007, What is the best control strategy for multiple infectious disease outbreaks?, Proc Biol Sci, 274, 833, 10.1098/rspb.2006.0015

2000, Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria., Genetics, 154, 985, 10.1093/genetics/154.3.985

2004, Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution., Res Microbiol, 155, 60

2006, The role of compensatory mutations in the emergence of drug resistance., PLoS Comput Biol, 2

2006, Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses., J Virol, 80, 8787, 10.1128/JVI.00477-06

2007, Modeling systems-level regulation of host immune responses., PLoS Comput Biol, 3

2007, Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials., Am J Epidemiol, 165, 212

2006, Mitigation strategies for pandemic influenza in the United States., Proc Natl Acad Sci U S A, 103, 5935, 10.1073/pnas.0601266103

2006, Strategies for mitigating an influenza pandemic., Nature, 442, 448, 10.1038/nature04795